Risk assessment and integrated process modeling–an improved QbD approach for the development of the bioprocess control strategy
A Process characterization is a regulatory imperative for process validation within the biopharmaceutical industry. Several individual steps must be conducted to achieve the final control strategy. For that purpose, tools from the Quality by Design (QbD) toolbox are often considered. These tools req...
Main Authors: | Daniel Borchert, Diego A. Suarez-Zuluaga, Yvonne E. Thomassen, Christoph Herwig |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2020-11-01
|
Series: | AIMS Bioengineering |
Subjects: | |
Online Access: | http://www.aimspress.com/article/10.3934/bioeng.2020022/fulltext.html |
Similar Items
-
Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment
by: Lalintip Hocharoen, et al.
Published: (2021-05-01) -
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
by: Lidia Gurba-Bryśkiewicz, et al.
Published: (2023-10-01) -
Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD)
by: Isa Martins Fukuda, et al.
Published: (2018-11-01) -
Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering
by: Kakon Nag, et al.
Published: (2023-08-01) -
Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets
by: Ahmed Ramadan, et al.
Published: (2021-06-01)